References
1. Mainardi T, Kapoor S, Bielory L. Complementary and alternative
medicine: herbs, phytochemicals and vitamins and their immunologic
effects. J Allergy Clin Immunol. 2009;123(2):283-294; quiz
295-286.
2. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and
survival of mice on a high-calorie diet. Nature.2006;444(7117):337-342.
3. Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of
resveratrol, a natural product derived from grapes. Science.1997;275(5297):218-220.
4. Malaguarnera L. Influence of Resveratrol on the Immune Response.Nutrients. 2019;11(5).
5. Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. Curcumin, the
golden nutraceutical: multitargeting for multiple chronic diseases.Br J Pharmacol. 2017;174(11):1325-1348.
6. Oz M, El Nebrisi EG, Yang KS, Howarth FC, Al Kury LT. Cellular and
Molecular Targets of Menthol Actions. Front Pharmacol.2017;8:472.
7. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer
mediates the induction of phase II detoxifying enzyme genes through
antioxidant response elements. Biochem Biophys Res Commun.1997;236(2):313-322.
8. Kanada S, Nishiyama C, Nakano N, et al. Critical role of
transcription factor PU.1 in the expression of CD80 and CD86 on
dendritic cells. Blood. 2011;117(7):2211-2222.
9. Kitamura N, Yokoyama H, Yashiro T, et al. Role of PU.1 in MHC class
II expression through transcriptional regulation of class II
transactivator pI in dendritic cells. J Allergy Clin Immunol.2012;129(3):814-824.e816.
10. Ito N, Sakata F, Hachisu M, et al. The Ccl17 gene encoding TARC is
synergistically transactivated by PU.1 and IRF4 driven by the mammalian
common promoter in dendritic cells. Allergy. 2021.
11. Kensler TW, Egner PA, Agyeman AS, et al. Keap1-nrf2 signaling: a
target for cancer prevention by sulforaphane. Top Curr Chem.2013;329:163-177.
12. Helou DG, Noël B, Gaudin F, et al. Cutting Edge: Nrf2 Regulates
Neutrophil Recruitment and Accumulation in Skin during Contact
Hypersensitivity. J Immunol. 2019;202(8):2189-2194.
13. Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN.
Nrf2-deficient mice have an increased susceptibility to dextran sulfate
sodium-induced colitis. Cancer Res. 2006;66(24):11580-11584.
14. Ogawa T, Ishitsuka Y, Inoue S, et al. Nuclear Factor Erythroid
2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under
Psoriatic Skin Inflammation. Am J Pathol. 2020;190(3):577-585.
15. Yoh K, Itoh K, Enomoto A, et al. Nrf2-deficient female mice develop
lupus-like autoimmune nephritis. Kidney Int.2001;60(4):1343-1353.
16. Johnson DA, Amirahmadi S, Ward C, Fabry Z, Johnson JA. The absence
of the pro-antioxidant transcription factor Nrf2 exacerbates
experimental autoimmune encephalomyelitis. Toxicol Sci.2010;114(2):237-246.
17. Schön MP, Schön M. Imiquimod: mode of action. Br J Dermatol.2007;157 Suppl 2:8-13.
18. Gilliet M, Conrad C, Geiges M, et al. Psoriasis triggered by
toll-like receptor 7 agonist imiquimod in the presence of dermal
plasmacytoid dendritic cell precursors. Arch Dermatol.2004;140(12):1490-1495.
19. van der Fits L, Mourits S, Voerman JS, et al. Imiquimod-induced
psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17
axis. J Immunol. 2009;182(9):5836-5845.
20. Kobayashi EH, Suzuki T, Funayama R, et al. Nrf2 suppresses
macrophage inflammatory response by blocking proinflammatory cytokine
transcription. Nat Commun. 2016;7:11624.